Ftse Mib
34.815,91
0,46%
DAX
18.742,22
-0,08%
S&P 500
5.221,42
-0,02%
NASDAQ
16.388,24
0,29%
Bitcoin
62.577,47
-0,52%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Tyra Biosciences Inc (TYRA) Tyra Biosciences Inc (TYRA) Notizie

Tyra Biosciences Inc

TYRA
18,50
1,15 (6,63%)
14 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
09/5/202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202422:46EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/5/202422:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:08EDGAR2Form 8-K - Current report
09/5/202422:05PRNUSTyra Biosciences Reports First Quarter 2024 Financial..
07/5/202422:34EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/5/202422:29EDGAR2Form 8-K - Current report
07/5/202422:05PRNUSTyra Biosciences Announces Appointments of Susan Moran,..
19/3/202421:05PRNUSTyra Biosciences Reports Fourth Quarter and Full Year 2023..
08/3/202423:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202400:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:05PRNUSTyra Biosciences to Present at Upcoming Investor Conferences
15/2/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202422:36EDGAR2Form D - Notice of Exempt Offering of Securities
12/2/202422:46EDGAR2Form 144 - Report of proposed sale of securities
10/2/202401:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:05PRNUSTyra Biosciences to Present at Oppenheimer's 34th Annual..
07/2/202402:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202422:56EDGAR2Form 144 - Report of proposed sale of securities
05/2/202412:05EDGAR2Form 8-K - Current report
02/2/202423:04EDGAR2Form 144 - Report of proposed sale of securities
02/2/202414:00PRNUSTyra Biosciences, Inc. Announces $200 Million Private..
01/2/202423:30PRNUSTyra Biosciences Receives FDA Rare Pediatric Disease..
01/2/202423:24EDGAR2Form 8-K - Current report
22/12/202315:00EDGAR2Form 8-K - Current report
22/12/202315:00PRNUSTyra Biosciences Doses First Patient with TYRA-200 and..
08/11/202322:05PRNUSTyra Biosciences to Participate in 2023 Jefferies London..
07/11/202322:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202322:07EDGAR2Form 8-K - Current report
07/11/202322:05PRNUSTyra Biosciences Reports Third Quarter 2023 Financial..
26/10/202322:50EDGAR2Form 8-K - Current report
21/9/202314:00PRNUSTyra Biosciences Announces Oral Presentations on TYRA-300..
20/9/202301:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202322:05PRNUSTyra Biosciences to Participate at 2023 Cantor Global..
10/8/202322:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:21EDGAR2Form 8-K - Current report
10/8/202322:05PRNUSTyra Biosciences Reports Second Quarter 2023 Financial..
01/8/202323:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202323:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202314:54DJNTyra Biosciences Gets FDA Orphan Designation for TYRA-300 in..
01/8/202314:00PRNUSTyra Biosciences Announces FDA Orphan Drug Designation for..
22/7/202302:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202301:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/7/202300:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202323:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/6/202302:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/5/202314:00PRNUSTyra Biosciences to Participate in Upcoming Investor..
Apertura: 17,61 Min: 17,61 Max: 18,66
Chiusura: 17,35

La tua Cronologia

NASDAQ
TYRA
Tyra Biosciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network